Phase III randomized, double-blind study comparing single-dose intravenous peramivir with oral oseltamivir in patients with seasonal influenza virus infection.
about
Peramivir: A Novel Intravenous Neuraminidase Inhibitor for Treatment of Acute Influenza InfectionsSafety and efficacy of peramivir for influenza treatmentPeramivir injection in the treatment of acute influenza: a review of the literatureUse of intravenous peramivir for treatment of severe influenza A(H1N1)pdm09Progress of small molecular inhibitors in the development of anti-influenza virus agents.Japanese Surveillance Systems and Treatment for Influenza.Efficacy, safety, and pharmacokinetics of intravenous peramivir in children with 2009 pandemic H1N1 influenza A virus infectionPeramivir for the treatment of influenza.Peramivir use for treatment of hospitalized patients with influenza A(H1N1)pdm09 under emergency use authorization, October 2009-June 2010.Influenza outbreaks in Singapore: epidemiology, diagnosis, treatment and prevention.Clinical use of approved influenza antivirals: therapy and prophylaxis.Newer influenza antivirals, biotherapeutics and combinations.Comparison of Efficacy of Intravenous Peramivir and Oral Oseltamivir for the Treatment of Influenza: Systematic Review and Meta-Analysis.A cutting-edge view on the current state of antiviral drug development.Efficacy of repeated intravenous administration of peramivir against highly pathogenic avian influenza A (H5N1) virus in cynomolgus macaques.The mechanisms of delayed onset type adverse reactions to oseltamivir.Influenza viral load and peramivir kinetics after single administration and proposal of regimens for peramivir administration against resistant variantsEfficacy of combination therapy with oseltamivir phosphate and azithromycin for influenza: a multicenter, open-label, randomized studyPopulation pharmacokinetics of peramivir in healthy volunteers and influenza patients.Efficacy of repeated intravenous injection of peramivir against influenza A (H1N1) 2009 virus infection in immunosuppressed mice.Antiviral treatment of influenza in South Korea.Viral Respiratory Infections of Adults in the Intensive Care Unit.Peramivir: an intravenous neuraminidase inhibitor.Efficacy and Safety of Intravenous Peramivir Compared With Oseltamivir in High-Risk Patients Infected With Influenza A and B Viruses: A Multicenter Randomized Controlled Study.Peramivir is as effective as oral oseltamivir in the treatment of severe seasonal influenza.Evaluation of intravenous peramivir for treatment of influenza in hospitalized patients.Influenza-B associated rhabdomyolysis and acute renal failure.Clinical and virologic effects of four neuraminidase inhibitors in influenza A virus-infected children (aged 4-12 years): an open-label, randomized study in Japan.Clinical efficacy of peramivir in adult patients with seasonal influenza during the winter of 2012 in Japan.Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association.Safety and Effectiveness of Peramivir in Korean Adult Influenza Patients: Prospective Observational Study Based on Post-Marketing Surveillance Data
P2860
Q26749578-A00F1E5C-3B72-4ED8-A45F-77F2439C7D49Q27027408-B8CC96D5-2EEF-41D5-9577-3FC7F4C7BCA8Q28068310-76F5F575-E722-492E-8FF4-439081B8DCB5Q28480880-DEAE6EB4-5BC0-4DD0-B1E9-C275A25240B8Q30234943-AA5EDD58-60A0-4980-A133-60358D2AE6F0Q30239895-65075C50-2C86-4B42-B6A9-2FCB2DD49801Q30408582-21A1C4BC-22C0-43F7-B44D-7C745B9421C8Q30413154-379B3ABD-B274-46C6-AEF8-0F50970A967DQ30415224-0EB818C5-D463-4BEB-989E-EA69594536F9Q30420892-ACD05D74-EB82-4951-ADCD-2C58F60BCDE3Q30425343-BF6CE31A-8D02-49D1-862D-7A68C1184F99Q30456363-4821F9C1-4762-4C0C-9629-D1E5A5C79259Q33735002-B7479FE1-4033-45E2-A55D-F615BA35E4B0Q34036018-4FAAA13A-3734-4BB8-9E36-89E0DF9573D3Q34058036-7F419252-7DF6-435E-8BF7-8D172523C7E7Q34677448-93CDF50D-5730-4314-A3D0-C6BB47F9B7BFQ35076812-38FD9143-30B2-44FB-BF97-D2D55E0BE8DAQ35121720-917D81F4-3A0B-465A-B319-9CAE595E369CQ36158190-AE23F77E-74AD-48E3-9940-CE901B44AB7AQ36785817-4E262EF8-C20F-413E-8567-565F4A901642Q38401883-FC737CBB-23D0-4BD7-B80B-D822785659F3Q38491990-33F6463A-BC2D-4E1C-BEC3-3CCC86555B5AQ38543777-8D0DD4D7-0B75-494F-B8DA-20642290B80EQ38650234-7744ABE3-BA27-4132-AB1E-D683C7B15BC1Q40970018-A8436546-FA8C-440A-83DF-8B45E35F22ACQ42200492-9CD9BAA0-7C8A-4119-839E-1368403D9D63Q42276919-38D3E3DF-48D8-4952-98CC-C21091804F6EQ47559944-82E5AADA-4AB3-4EC2-9E0B-792BC1A7B049Q51847339-CC35920B-185A-4C15-A1D0-B1EE2CC34EF8Q53516441-03A5EC9C-E148-4AEA-B802-7A3A796444BDQ56890304-4BDB2B7B-0607-4676-B920-3E15564CD6AF
P2860
Phase III randomized, double-blind study comparing single-dose intravenous peramivir with oral oseltamivir in patients with seasonal influenza virus infection.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Phase III randomized, double-b ...... nal influenza virus infection.
@ast
Phase III randomized, double-b ...... nal influenza virus infection.
@en
type
label
Phase III randomized, double-b ...... nal influenza virus infection.
@ast
Phase III randomized, double-b ...... nal influenza virus infection.
@en
prefLabel
Phase III randomized, double-b ...... nal influenza virus infection.
@ast
Phase III randomized, double-b ...... nal influenza virus infection.
@en
P2093
P2860
P356
P1476
Phase III randomized, double-b ...... nal influenza virus infection.
@en
P2093
Hee-Jin Cheong
Hiroshi Kida
Jingoro Shimada
Jun-ichi Kadota
Muh-Yong Yen
Nobuo Hirotsu
S-021812 Clinical Study Group
Shigeru Kohno
Tadashi Ishida
P2860
P304
P356
10.1128/AAC.00360-11
P407
P577
2011-08-08T00:00:00Z